Conatus Pharmaceuticals Inc (NASDAQ:CNAT)
| 7.84 Real-Time Quote |  +0.09 / +1.16%Today’s Change | 5.06 Today|||52-Week Range 15.67 | +21.55% Year-to-Date |
Latest CNAT News | Press Releases
No recent news for Conatus Pharmaceuticals Inc.
Today’s Trading
| Previous close | 7.75 |
| Today’s open | 7.90 |
| Day’s range | 7.71 - 8.02 |
| Volume | 79,819 |
| Average volume (3 months) | 681,484 |
| Market cap | $121.1M |
| Dividend yield | -- |
Data as of 10:32am ET, 07/23/2014
Growth & Valuation
| Earnings growth (last year) | +33.68% |
| Earnings growth (this year) | -162.86% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CORICorium International... | -0.02 | -0.29% |
| ATHXAthersys Inc | +0.05 | +3.14% |
| TNXPTonix Pharmaceutical... | -0.03 | -0.26% |
| EPRSEpirus Biopharmaceut... | -0.26 | -2.71% |
Data as of 10:33am ET, 07/23/2014
Financials
| Next reporting date | September 8, 2014 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Steven J. Mento |
Chief Financial Officer, Secretary & SVP Charles J. Cashion |
Corporate headquarters San Diego, California |
Forecasts
.
